DTA members include companies and organizations engaged in the manufacture, support, and utilization of digital therapeutics. Healthcare providers, patient groups, and payers are actively engaged in DTA’s work and mission.
The Alliance appreciates the efforts of fellow organizations engaged in the evidence-driven advancement of digital therapeutics to improve patient outcomes. DTA is committed to supporting the ongoing work of organizations aligned with our mission.
Digital therapeutics (DTx) deliver evidence-based therapeutic interventions to patients that are driven by high quality software programs to prevent, manage, or treat a medical disorder or disease. They are used independently or in concert with medications, devices, or other therapies to optimize patient care and health outcomes.
DTx products incorporate advanced technology best practices relating to design, clinical validation, usability, and data security. They are reviewed and cleared or approved by regulatory bodies as required to support product claims regarding risk, efficacy, and intended use.
Digital therapeutics empower patients, healthcare providers, and payers with intelligent and accessible tools for addressing a wide range of conditions through high quality, safe, and effective data-driven interventions.